RA Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

RA Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,900	Closed	-$1.1M	–	50
2015 Q2	$1.1M	Sell	9,900 -7,700	-44%	-$829K	0.11%	51
2015 Q1	$1.66M	Hold	17,600	–	–	0.16%	42
2014 Q4	$1.97M	Hold	17,600	–	–	0.21%	36
2014 Q3	$1.08M	Buy	+17,600	New	+$759K	0.13%	33
2013 Q4	–	Sell	-70,000	Closed	-$1.96M	–	33
2013 Q3	$1.96M	Buy	+70,000	New	+$1.93M	0.2%	36

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RA Capital Management's AGIO Position: Q3 2015 in Review

RA Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 9,900 shares — an estimated $1.1M sold.

RA Capital Management first reported a position in AGIO in Q3 2013 and held it in 5 quarters. The position peaked at $1.97M in Q4 2014. 151 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

RA Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
RA Capital Management sold 9,900 Agios Pharmaceuticals shares in Q3 2015, an estimated $1.1M.
RA Capital Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 5 quarters.
RA Capital Management's Agios Pharmaceuticals position peaked at $1.97M in Q4 2014.
151 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.